BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 27666964)

  • 1. lncRNA-SNHG7 promotes the proliferation, migration and invasion and inhibits apoptosis of lung cancer cells by enhancing the FAIM2 expression.
    She K; Huang J; Zhou H; Huang T; Chen G; He J
    Oncol Rep; 2016 Nov; 36(5):2673-2680. PubMed ID: 27666964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-193b availability is antagonized by LncRNA-SNHG7 for FAIM2-induced tumour progression in non-small cell lung cancer.
    She K; Yan H; Huang J; Zhou H; He J
    Cell Prolif; 2018 Feb; 51(1):. PubMed ID: 29131440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA-SNHG7 regulates proliferation, apoptosis and invasion of bladder cancer cells assurance guidelines.
    Zhong X; Long Z; Wu S; Xiao M; Hu W
    J BUON; 2018; 23(3):776-781. PubMed ID: 30003751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced expression of long non-coding RNA ZXF1 promoted the invasion and metastasis in lung adenocarcinoma.
    Zhang L; Zhou XF; Pan GF; Zhao JP
    Biomed Pharmacother; 2014 May; 68(4):401-7. PubMed ID: 24721325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA SNHG7 promotes the proliferation and inhibits apoptosis of gastric cancer cells by repressing the P15 and P16 expression.
    Wang MW; Liu J; Liu Q; Xu QH; Li TF; Jin S; Xia TS
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4613-4622. PubMed ID: 29131253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SNHG7 and FAIM2 are up-regulated and co-expressed in colorectal adenocarcinoma tissues.
    Ziaee F; Hajjari M; Kazeminezhad RS; Behmanesh M
    Klin Onkol; 2020; 33(6):445-449. PubMed ID: 33685194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
    Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
    Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cav-1 promote lung cancer cell proliferation and invasion through lncRNA HOTAIR.
    Liu W; Yin NC; Liu H; Nan KJ
    Gene; 2018 Jan; 641():335-340. PubMed ID: 29080835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA H19 is responsible for the progression of lung adenocarcinoma by mediating methylation-dependent repression of CDH1 promoter.
    Gao LM; Xu SF; Zheng Y; Wang P; Zhang L; Shi SS; Wu T; Li Y; Zhao J; Tian Q; Yin XB; Zheng L
    J Cell Mol Med; 2019 Sep; 23(9):6411-6428. PubMed ID: 31317666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA HOXA11-AS promotes proliferation and invasion by targeting miR-124 in human non-small cell lung cancer cells.
    Yu W; Peng W; Jiang H; Sha H; Li J
    Tumour Biol; 2017 Oct; 39(10):1010428317721440. PubMed ID: 29034803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA CCAT1 promotes human retinoblastoma SO-RB50 and Y79 cells through negative regulation of miR-218-5p.
    Zhang H; Zhong J; Bian Z; Fang X; Peng Y; Hu Y
    Biomed Pharmacother; 2017 Mar; 87():683-691. PubMed ID: 28088735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Noncoding RNA CPS1-IT1 Suppresses Cell Proliferation and Metastasis in Human Lung Cancer.
    Xiaoguang Z; Meirong L; Jingjing Z; Ruishen Z; Qing Z; Xiaofeng T
    Oncol Res; 2017 Mar; 25(3):373-380. PubMed ID: 27662619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of lncRNA SNHG7 inhibited cell proliferation and migration in bladder cancer through activating Wnt/β-catenin pathway.
    Chen Y; Peng Y; Xu Z; Ge B; Xiang X; Zhang T; Gao L; Shi H; Wang C; Huang J
    Pathol Res Pract; 2019 Feb; 215(2):302-307. PubMed ID: 30527358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of long non-coding RNA ATB indicates a poor prognosis and regulates cell proliferation and metastasis in non-small cell lung cancer.
    Ke L; Xu SB; Wang J; Jiang XL; Xu MQ
    Clin Transl Oncol; 2017 May; 19(5):599-605. PubMed ID: 27878433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA SNHG7 promotes development of breast cancer by regulating microRNA-186.
    Luo X; Song Y; Tang L; Sun DH; Ji DG
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7788-7797. PubMed ID: 30536320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA SNHG7 sponges miR-216b to promote proliferation and liver metastasis of colorectal cancer through upregulating GALNT1.
    Shan Y; Ma J; Pan Y; Hu J; Liu B; Jia L
    Cell Death Dis; 2018 Jun; 9(7):722. PubMed ID: 29915311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma.
    Zhang HM; Yang FQ; Chen SJ; Che J; Zheng JH
    Tumour Biol; 2015 Apr; 36(4):2947-55. PubMed ID: 25480417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA SNHG7 contributes to tumorigenesis and progression in breast cancer by interacting with miR-34a through EMT initiation and the Notch-1 pathway.
    Sun X; Huang T; Liu Z; Sun M; Luo S
    Eur J Pharmacol; 2019 Aug; 856():172407. PubMed ID: 31132353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA SNHG7 contributes to cell proliferation, invasion and prognosis of cervical cancer.
    Zeng J; Ma YX; Liu ZH; Zeng YL
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9277-9285. PubMed ID: 31773679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of LncRNA SNHG7 inhibited epithelial-mesenchymal transition in prostate cancer though miR-324-3p/WNT2B axis in vitro.
    Han Y; Hu H; Zhou J
    Pathol Res Pract; 2019 Oct; 215(10):152537. PubMed ID: 31324390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.